|
Market Closed -
London S.E.
09:05:09 18/08/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 142.00 GBX | -2.07% |
|
-6.58% | +10.94% |
| 29/07 | Diaceutics PLC Reports Revenue Results for the Half Year Ended 30 June 2026 | CI |
| 02/06 | Diaceutics PLC, 2025 Earnings Call, May 26, 2026 |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | - | 2.99x | - | 2.47x | 11.25x | 36.03x | -.--% | 17Cr | |
| -114.08x | 7.7x | 0.3x | 25.07x | 62.22x | -89.47x | -.--% | 7.37TCr | |
| -12.49x | - | -0.02x | 6.98x | 16.97x | 72.49x | - | 375.76Cr | |
| 103.72x | 7.05x | 1.34x | 13.83x | 21.56x | 128.02x | 0.25% | 372.13Cr | |
| 33.88x | 3.58x | 0.48x | 2.53x | 21.76x | 36.91x | 1.4% | 370.21Cr | |
| 34.95x | 12.71x | 2.17x | 10.98x | 23.72x | 27.61x | 1.96% | 201.26Cr | |
| 29.72x | 2.45x | 3.08x | 4.01x | 15.98x | 20.75x | 0.6% | 138.41Cr | |
| -78.89x | 3.94x | 0.93x | - | - | - | 0.09% | 134.59Cr | |
| 15.85x | 4.68x | 0.4x | - | - | - | 0.37% | 117.33Cr | |
| 37.58x | 7.83x | 1.06x | 15.51x | 24.14x | 26.43x | 0.62% | 115.18Cr | |
| -2.37x | - | 0.17x | 5.07x | 8.34x | 70.36x | -.--% | 60Cr | |
| -61.11x | 6.36x | 0.7x | 2.24x | 16.31x | -66.65x | - | 18Cr | |
| Average | -1.20x | 5.93x | 0.97x | 8.87x | 22.23x | 26.25x | 0.53% | 774.01Cr | |
| Weighted average by Cap. | -85.07x | 7.43x | 0.44x | 21.95x | 54.42x | -61.49x | 0.14% |
- Stock Market
- Stocks
- DXRX Stock
- Sector Diaceutics PLC
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
